Reply to: Letter to the editor regarding the article 'Prostate cancer outcomes following whole-gland and focal high-intensity focused ultrasound'.

Autor: Parry MG; Department of Health Services Research and Policy, The London School of Hygiene and Tropical Medicine (LSHTM), London, UK.; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Sujenthiran A; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK.; Flatiron, London, UK., Nossiter J; Department of Health Services Research and Policy, The London School of Hygiene and Tropical Medicine (LSHTM), London, UK.; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Morris M; Department of Health Services Research and Policy, The London School of Hygiene and Tropical Medicine (LSHTM), London, UK.; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Berry B; Department of Health Services Research and Policy, The London School of Hygiene and Tropical Medicine (LSHTM), London, UK.; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Nathan A; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK.; University College London, London, UK., Aggarwal A; Department of Health Services Research and Policy, The London School of Hygiene and Tropical Medicine (LSHTM), London, UK.; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, UK., Payne H; Department of Oncology, University College London Hospitals, London, UK., van der Meulen J; Department of Health Services Research and Policy, The London School of Hygiene and Tropical Medicine (LSHTM), London, UK., Clarke NW; Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK.

Publikováno v: BJU international [BJU Int] 2024 Aug; Vol. 134 (2), pp. 313. Date of Electronic Publication: 2024 Mar 22.

Prostate cancer outcomes following whole-gland and focal high-intensity focused ultrasound.

Autor: Parry MG; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of UK, London, UK., Sujenthiran A; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of UK, London, UK.; Flatiron, London, UK., Nossiter J; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of UK, London, UK., Morris M; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of UK, London, UK., Berry B; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of UK, London, UK., Nathan A; The National Prostate Cancer Audit, Clinical Effectiveness Unit, Royal College of Surgeons of UK, London, UK.; University College London, London, UK., Aggarwal A; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, UK., Payne H; Department of Oncology, University College London Hospitals, London, UK., van der Meulen J; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK., Clarke NW; Departments of Urology, The Christie and Salford Royal Hospitals, Manchester, UK.

Publikováno v: BJU international [BJU Int] 2023 Nov; Vol. 132 (5), pp. 568-574. Date of Electronic Publication: 2023 Jul 25.

Impact of the COVID-19 pandemic on the diagnosis and treatment of men with prostate cancer.

Autor: Nossiter J; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Morris M; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Parry MG; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Sujenthiran A; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Cathcart P; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., van der Meulen J; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK., Aggarwal A; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Department of Cancer Epidemiology, Population, and Global Health, King's College London, London, UK., Payne H; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK., Clarke NW; Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK.

Publikováno v: BJU international [BJU Int] 2022 Aug; Vol. 130 (2), pp. 262-270. Date of Electronic Publication: 2022 Feb 15.

Hospital volume and outcomes after radical prostatectomy: a national population-based study using patient-reported urinary continence and sexual function.

Autor: Nossiter J; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK. jnossiter@rcseng.ac.uk.; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK. jnossiter@rcseng.ac.uk., Morris M; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Cowling TE; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Parry MG; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Sujenthiran A; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Aggarwal A; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Department of Cancer Epidemiology, Population, and Global Health, King's College London, London, UK., Payne H; Department of Oncology, University College London Hospitals NHS FoundatIon Trust, London, UK., van der Meulen J; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK., Clarke NW; Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Salford, UK., Cathcart P; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Jun; Vol. 26 (2), pp. 264-270. Date of Electronic Publication: 2021 Sep 08.

A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer.

Autor: Fankhauser CD; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; University of Zurich, Zurich, Switzerland; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland. Electronic address: cdfankhauser@gmail.com., Parry MG; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Research Group, Manchester University, Manchester, United Kingdom., Ali A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; GU Cancer/FASTMAN Research Group, Manchester University, Manchester, United Kingdom., Cowling TE; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Research Group, Manchester University, Manchester, United Kingdom., Nossiter J; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Research Group, Manchester University, Manchester, United Kingdom., Sujenthiran A; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom., Berry B; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Research Group, Manchester University, Manchester, United Kingdom., Morris M; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Research Group, Manchester University, Manchester, United Kingdom., Aggarwal A; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Research Group, Manchester University, Manchester, United Kingdom; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust., Payne H; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Department of Clinical Oncology University College London Hospital NHS Trust, London, United Kingdom., van der Meulen J; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, GU Cancer/FASTMAN Research Group, Manchester University, Manchester, United Kingdom., Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; National Prostate Cancer Audit, Royal College of Surgeons of England, London, UK; Department of Urology, Salford Royal NHS Foundation Trust, Manchester, UK.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Mar; Vol. 181, pp. 70-78. Date of Electronic Publication: 2022 Dec 26.